Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
27 Feb - 24 Jun 2003
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2003
Report date:
2003

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
(5Z)-5-(2-methylpropylidene)imidazolidine-2,4-dione
EC Number:
700-726-4
Cas Number:
1369499-44-4
Molecular formula:
C7H10N2O2
IUPAC Name:
(5Z)-5-(2-methylpropylidene)imidazolidine-2,4-dione

Test animals

Species:
rat
Strain:
other: CD / Crl: CD
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: males approx. 6 weeks, females approx. 7 weeks
- Weight at study initiation: males 192-201 g, females 180-188 g
- Fasting period before study: feeding was discontinued approx. 16 hours before administration
- Housing: 2-3 animals/cage
- Diet: ad libitum (ssniff® R/M-H V1530, ssniff Spezialdiäten GmbH, D-59494 Soest, Germany)
- Water: ad libitum (tap water)
- Acclimation period: 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 55 ± 15
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: 17.03.2003 To: 10.04.2003

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: 0.8% aqueous hydroxypropylmethylcellulose
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 200 mg/mL in 0.8% aqueous hydroxypropylmethylcellulose gel

MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg b.w.
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
3
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: before and immediately, at 5, 15, 30 and 60 min, as well as at 3, 6 and 24 hours and 14 days after administration
- Observations on mortality were made at least once daily; the time of death was recorded as precisely as possible
- Observations on clinical signs: changes of skin and fur, eyes and mucous membranes, respiratory and the circulatory, autonomic and central nervous system, somatomotor activity as well as behaviour pattern were observed at least once a day until all symptoms subsided, thereafter each working day. Attention was also paid to possible tremor, convulsions, salivation, diarrhoea, lethargy, sleep and coma.
- Individual body weights were recorded before administration of the substance and thereafter in weekly intervals up to the end of the study, and at death; changes in weight were calculated and recorded
- Necropsy of survivors performed: yes
- Other examinations performed: gross examination of organs at necropsy ; all gross pathological changes were recorded; no histopathology was carried out as no macroscopical findings were noted at autopsy; autopsy and macroscopic inspection of animals which died prematurely were carried out as soon as possible after exitus

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
1 of 3 male and 1 of 3 female animals died prematurely within 24 hours after dosing.
Clinical signs:
other: Slightly to moderately reduced motility, slight to moderate ataxia, slight to moderate dyspnoea, ptosis.
Gross pathology:
No macroscopical findings were noted at autopsy.

Applicant's summary and conclusion

Interpretation of results:
Category 5 based on GHS criteria
Conclusions:
The oral LD50 value of the test material in male and female rats was determined to be >2000 mg/kg bw. One male and one female animals died prematurely within 24 hours after dosing.